Posaconazole 200 MG/5 ML susp 105ML
Ended Awarded
- Contract number
- SPE2DR26FCP1P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,962
Award facts
- Contract value 100% obligated
- $1,961.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,961.60 to AmerisourceBergen Drug Corp for Posaconazole 200 mg/5 ml Suspension (105ml) on November 13, 2025, with an ultimate completion date of November 14, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
The posaconazole delivery falls within AmerisourceBergen Drug Corp's extensive portfolio of pharmaceutical products supplied to federal customers including the Defense Health Agency and U.S. Coast Guard. Posaconazole is an antifungal medication commonly used in military medical settings for both prophylaxis and treatment of fungal infections in immunocompromised patients. The firm fixed pricing structure and rapid completion timeline reflect the operational nature of this supply chain delivery under the broader DLA pharmaceutical prime vendor framework, which continues to support diverse therapeutic domains across military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FCP1P?
SPE2DR26FCP1P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FCP1P worth?
The government has obligated $1,962 on SPE2DR26FCP1P.
Is contract SPE2DR26FCP1P an order under another contract?
Yes. SPE2DR26FCP1P is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCP1P competed?
The extent of competition for SPE2DR26FCP1P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award